Competitive Technologies, Inc.
Competitive Technologies, Inc.
- ISIN: US2045121074
- Land: .
Nachricht vom 15.07.2011 | 17:39
Competitive Technologies to Sell BiCOM's Medical Devices
Competitive Technologies, Inc.
15.07.2011 17:39
---------------------------------------------------------------------------
FAIRFIELD, Conn., 2011-07-15 17:39 CEST (GLOBE NEWSWIRE) --
Competitive Technologies, Inc. (OTCQX:CTTC) today announced that it has entered
into a strategic marketing agreement with Long Beach, New York-based BiCOM,
Inc. In the agreement CTTC has agreed to sell BiCOM's patented products in the
U.S. and various international markets.
For the U.S. and international markets, CTTC will offer BiCOM's FDA cleared
Diaton tonometer, developed and manufactured in Russia, which allows medical
professionals to measure intraocular pressure for glaucoma through the eyelid,
without anesthesia or direct contact with the eyeball. Internationally, CTTC
will offer BiCOM's 'Magnetic Therapy DIATON' for magnetic therapy.
'Joining forces with CTTC is a natural progression for BiCOM Inc., where
complementary skills, national and international connections and unique product
offerings will make this strategic relationship a power house with many growth
opportunities,' said Roman Iospa, CEO of BiCOM Inc.
'This partnership is positive for both of us,' said Aris Despo, CTTC's EVP.
'Working with BiCOM allows us to offer unique medical products to our expanding
domestic and international channels that will add revenue growth opportunities
in niche markets for our sales representatives, our distributors and for CTTC.
We also anticipate BiCOM working with us to expand the Calmare Scrambler to
Russia and other foreign markets where they already have established
distribution for BiCOM products. We will continue to evaluate new opportunities
which enhance CTTC's value by fulfilling identified unmet needs in the
marketplace.'
About BiCOM Inc.
BiCOM, with its 19 years of tradition and global clientele, has proven to be an
enterprise with the highest level of professionalism, integrity and financial
solvency. A unique team of engineers, medical, legal and business experts makes
BiCOM Inc. the right place for global talent to find support and guidance.
BiCOM Inc. sees its mission in bringing to market innovative products developed
and manufactured worldwide.
BiCOM's main product line includes a unique Diaton tonometer which allows eye
care and medical professionals to measure intraocular pressure (IOP) for
glaucoma through the eyelid, without anesthesia and direct contact with the
eyeball (see http://www.TonometerDiaton.com) and the 'Magnetic Therapy DIATON'
unit which makes use of the fact that certain types of magnetism with
low-intensity are capable of performing general therapeutic and curative
functions (see http://www.MagneticTherapyDiaton.com).
About Competitive Technologies, Inc.
Competitive Technologies is a global leader in developing and commercializing
innovative products and technologies. CTTC is multifaceted, providing
distribution, patent and technology transfer, sales and licensing services.
CTTC's staff is focused on the needs of customers and matching those
requirements with commercially viable products or technology solutions.
CTTC is the licensed worldwide distributor of the non-invasive Calmare(r) pain
therapy medical device, which incorporates the biophysical 'Scrambler Therapy(tm)'
technology developed in Italy by CTTC's client, Professor Giuseppe Marineo to
treat neuropathic pain, including cancer pain. The Calmare(r) device is currently
being manufactured for sale by CTTC's partner, GEOMC Co., Ltd. of Seoul, Korea.
For more information on the device, visit www.calmarett.com. Visit CTTC's
website: www.competitivetech.net.
Statements made about our future expectations are forward-looking statements
and subject to risks and uncertainties as described in our most recent Annual
Report on Form 10-K for the year ended July 31, 2010, filed with the SEC on
October 27, 2010, and other filings with the SEC, and are subject to change at
any time. Our actual results could differ materially from these forward-looking
statements. We undertake no obligation to update publicly any forward-looking
statement.
CONTACT: Jean Wilczynski, IR Services, LLC
860.434.2465
info@corpirservices.com
News Source: NASDAQ OMX
15.07.2011 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Competitive Technologies, Inc.
United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US2045121074
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Interaktiv
Weitere News
-
21.09.11 19:38
Competitive Technologies Announces New Interna ... -
21.09.11 19:38
Competitive Technologies Announces New Interna ... -
18.08.11 17:31
Competitive Technologies Announces Sale of 12 ... -
18.08.11 17:31
Competitive Technologies Announces Sale of 12 ... -
15.07.11 17:39
Competitive Technologies to Sell BiCOM's Medic ...
Anleihe im Fokus
8,25% Maritim-Offshore-Anleihe
Die besicherte Maritim-Offshore-Anleihe (WKN A1MLY9 / ISIN DE000A1MLY97) mit einem Volumen von bis zu € 25 Mio. und einem Zinssatz von 8,25% kann ab dem 21. Mai 2012 gezeichnet werden.
Die Laufzeit der Anleihe beträgt 2,5 Jahre, der Kupon wird halbjährlich bezahlt.
Event im Fokus
13. MKK
13. MKK - Münchner Kapitalmarkt Konferenz
am 23. & 24. Mai 2012
Über 20 Gesellschaften aus dem Small- und Mid-Cap Bereich präsentieren sich
im SOFITEL Munich Bayerpost
GBC-Fokusbox
HELMA Eigenheimbau: Rekordwerte
Im abgelaufenen Geschäftsjahr legte HELMA Eigenheimbau AG bei der Umsatz– und Ergebnisdynamik deutlich zu und erreichte damit neue Rekordwerte. Auf Basis unseres DCF-Modells haben wir einen 2012er fairen Unternehmenswert von 19 € je Aktie ermittelt. Unser Rating lautet „KAUFEN“.
News im Fokus
SAP AG: SAP erweitert Cloud-Geschäft mit Akquisition von Ariba
22. Mai 2012, 20:48
Der AKTIONÄR News

22. Mai 21:23 Dow unverändert - Facebook weiter unter Druck - Best Buy, General ...
22. Mai 16:37 DAX mit Rebound: BMW, BASF, Bayer, Süss Microtec, Morphosys, ...
22. Mai 16:00 Facebook: Anleger stinksauer
22. Mai 15:53 Chart-Check BASF: (Fast) wieder im Aufwärtstrend
22. Mai 14:34 Süss Microtec setzt zur Aufholjagd an
Aktuelle Research-Studie
MPH Mittelständische Pharma Holding AG
Original-Research: MPH Mittelständische Pharma Holding AG (von GBC AG): KAUFEN
22. Mai 2012